TACE (CT) Blocking Peptide

Home/Control Peptides/TACE (CT) Blocking Peptide

Pricing & Details

Product No.T204
Tumor Necrosis Factor-α Converting Enzyme
Formats AvailableView All
Product Type
Blocking Peptide
Alternate Names
ADAM17, CD156b, MGC71942, cSVP
Prod No.
Add to cart
T204-50 µg
50 µg
In stock
Min: 1
Step: 1
Contact Us For Academic mAb Advantage Pricing

Antibody Details

Product Details

Reactivity Species
Product Concentration
0.2 mg/ml
Amino Acid Location
This peptide sequence is located at amino acids 807 to 823 of Human TACE protein.
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
TACE (tumor necrosis factor-α-converting enzyme) is a pleiotropic metalloprotease also known as ADAM17 that is found to be constitutively expressed by intestinal epithelial cells.1 TACE is a major sheddase of TNF-α and its receptors, essential for the generation of soluble, mature molecules.2 TACE as a promising target of epidermal growth factor receptor (EGFR) axis inhibition in colorectal cancer (CRC)3 and a principal target for the treatment of TNF-dependent pathologies.4

Antigen Details

References & Citations

1. Masson D et al. (2009) Int J Mol Med. 23: 41 2. B Chodynicka et al. (2008) J European Acad Dermatol & Venereol. 22: 712 3. Coffey RJ et al. (2008) Clin Cancer Res. 14: 1182 4. Blobel CP et al. (2007) J Immunol. 179: 2689
Prod No.
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok